文献速递血栓与止血

妊娠期及产后下肢浅静脉血栓形成的发生率与预后:丹麦全国队列研究

Incidence and prognosis of superficial vein thrombosis during pregnancy and the post-partum period: a Danish nationwide cohort study.
PubMed 文献 · Lancet Haematol · 2023-03-24

该丹麦全国队列研究纳入1997年1月1日至2017年12月31日分娩的孕妇,计算妊娠各孕期及产后下肢浅静脉血栓形成(SVT)发生率及后续静脉血栓栓塞风险。共1276046次分娩中发生710例下肢SVT,总发生率0.6/1000人年;产后最高为1.6/1000人年。产前SVT患者后续静脉血栓栓塞风险显著升高(HR 83.3)。

要点

  • 妊娠相关下肢SVT总发生率为0.6/1000人年,产后升至1.6/1000人年。
  • 产前SVT妇女中10.4%发生静脉血栓栓塞,无SVT者仅0.1%。
  • 产前SVT后静脉血栓栓塞风险HR为83.3(95%CI 46.3-149.7)。

核心结论

  • 妊娠期及产后SVT发生率低,但妊娠期诊断SVT后同次妊娠发生静脉血栓栓塞的风险高。
  • 结果可能有助于医生和患者就妊娠相关SVT的抗凝管理做出决策。

研究设计与样本

  • 丹麦全国队列研究,数据来自丹麦医学出生登记、丹麦国家患者登记和丹麦国家处方登记。
  • 纳入1997年1月1日至2017年12月31日丹麦所有分娩孕妇,共1276046次分娩。
  • 计算各孕期及产前、产后每1000人年SVT发生率。
  • 对妊娠相关SVT妇女,计算同次妊娠或产后后续静脉血栓栓塞风险,并与无SVT的匹配孕妇队列比较,采用Cox比例风险分析。

主要发现

  • 从受孕至产后12周共诊断710例下肢SVT,总发生率为0.6/1000人年(95%CI 0.5-0.6)。
  • SVT发生率在孕早期为0.1/1000人年(95%CI 0.1-0.2),孕中期为0.2/1000人年(95%CI 0.2-0.3),孕晚期为0.5/1000人年(95%CI 0.5-0.6)。
  • 产后SVT发生率为1.6/1000人年(95%CI 1.4-1.7)。
  • 纳入分析的211例产前SVT妇女中22例(10.4%)诊断静脉血栓栓塞,无SVT妇女中为25例(0.1%)。
  • 产前SVT后静脉血栓栓塞的风险比HR为83.3(95%CI 46.3-149.7)。

关键数值与推荐

  • 妊娠相关SVT总发生率:0.6/1000人年(95%CI 0.5-0.6)。
  • 孕早期SVT发生率:0.1/1000人年(95%CI 0.1-0.2)。
  • 孕中期SVT发生率:0.2/1000人年(95%CI 0.2-0.3)。
  • 孕晚期SVT发生率:0.5/1000人年(95%CI 0.5-0.6)。
  • 产后SVT发生率:1.6/1000人年(95%CI 1.4-1.7)。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为这些结果可能有助于医生和患者就妊娠相关SVT的抗凝管理做出决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The incidence of superficial vein thrombosis (SVT) of the legs and the subsequent risk of venous thromboembolism during pregnancy and the post-partum period is unknown. To better understand the clinical course of SVT during these times, we aimed to estimate the incidence rate of SVT during pregnancy and in the post-partum period, as well as the risk of subsequent venous thromboembolism. METHODS: In this nationwide cohort study, we collected data on all pregnant women who delivered between Jan 1, 1997, and Dec 31, 2017, in Denmark were extracted from the Danish Medical Birth Register, the Danish National Patient Registry, and the Danish National Prescription Registry. Data on ethnicity were not available. Incidence rates per 1000 person-years were calculated for each trimester and the antepartum and post-partum period. Among women with a pregnancy-related SVT, risk of subsequent venous thromboembolism within the same pregnancy or post-partum period were calculated and compared with a matched cohort of pregnant women without SVT using Cox proportional hazards analysis. FINDINGS: During 1 276 046 deliveries, 710 diagnoses of lower extremity SVT occurred from conception up to 12 weeks postpartum (0·6 per 1000 person-years [95% CI 0·5-0·6]). The incidence rates of SVT per 1000 person-years were 0·1 (95% CI 0·1-0·2) during the during the first trimester, 0·2 (0·2-0·3) during the second trimester, and 0·5 (0·5-0·6) during the third trimester. The incidence rate was 1·6 per 1000 person-years (95% CI 1·4-1·7) during the post-partum period. Of the 211 women with antepartum SVT included in the analysis, 22 (10·4%) were diagnosed with venous thromboembolism, compared with 25 (0·1%) in women without SVT (hazard ratio 83·3 [95% CI 46·3-149·7]). INTERPRETATION: The incidence rate of SVT during pregnancy and the post-partum period was low. However, if SVT during pregnancy was diagnosed, the risk of developing venous thromboembolism during the same pregnancy was high. These results might help physicians and patients to make decisions about anticoagulant management of pregnancy-related SVT. FUNDING: None.

来源:Lancet Haematol,查看原文。版权归原作者所有。

引用

  1. Wiegers HMG, Körmendiné Farkas D, Horváth-Puhó E, et al. Incidence and prognosis of superficial vein thrombosis during pregnancy and the post-partum period: a Danish nationwide cohort study. Lancet Haematol. 2023. PMID: 36972715. doi:10.1016/S2352-3026(23)00013-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。